🔎 Trials Near Me

Inicio › Enfermedad pulmonar intersticial › Florida

Ensayos clínicos de Enfermedad pulmonar intersticial en Florida

25 estudios sobre Enfermedad pulmonar intersticial buscan participantes en Florida.

Ciudades en Florida

Texto oficial del estudio (inglés)

LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of Florida, Gainesville
  • New Access Research and Medical Services, Miami
  • Eunix Clinical Research, Orlando
  • y 1 más
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 29 sept 2026 · NCT05798923

Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • USA017, Gainesville
  • USA006, Naples
  • USA026, St. Petersburg
  • y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 sept 2026 · NCT07179380

FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression

  • Clinical Research Specialists LLC - Kissimmee, Kissimmee
  • Lakeland Regional Medical Center - Lakeland, Lakeland
  • Advanced Pulmonary Research Institute, Loxahatchee Groves
  • y 4 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07540988

A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases

  • Meris Clinical Research-Brandon-69466, Brandon
  • Miami VA Healthcare System, Miami
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 16 sept 2026 · NCT06806592

A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)

  • Clinical Research Site, Kissimmee
ReclutandoFase 3
Edades de 18 a 85 · Todos los sexos · Actualizado el 11 sept 2026 · NCT07816185

A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease

  • GSK Investigational Site, Jacksonville
  • GSK Investigational Site, Miami
ReclutandoFase 2/3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT05878717

A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis

  • Clinical Research Specialists LLC - Kissimmee, Kissimmee
ReclutandoFase 3
Edades de 40 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT07201922

A Study of the Efficacy and Safety of Belimumab in Adults With Interstitial Lung Disease Associated With Connective Tissue Disease

  • GSK Investigational Site, Gainesville
  • GSK Investigational Site, Naples
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 8 sept 2026 · NCT06572384

A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis

  • Cleveland Clinic Florida, Weston
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 4 sept 2026 · NCT06968845

Multi-site Study of the Clinical Impact of an AI-assisted Approach to Referring Patients With Interstitial Lung Disease for Diagnostic Evaluation of Pulmonary Hypertension

  • AdventHealth Orlando, Orlando
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT06911632

A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

  • Clinical Research Site, Kissimmee
ReclutandoFase 2
Edades de 18 a 85 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07333183

A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD

  • Tampa General Hospital, Tampa
ReclutandoFase 3
Edades de 18 a 80 · Todos los sexos · Actualizado el 2 sept 2026 · NCT07285655

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • University of Florida, Gainesville
  • NCH Research Institute, Naples
  • Advent Health Medical Group Advanced Lung Disease, Orlando
  • y 3 más
ReclutandoEstudio observacional
Edades de 18 en adelante · Todos los sexos · Actualizado el 26 ago 2026 · NCT06388421

Emapalumab MDA5 Rapidly Progressive Interstitial Lung Disease (RP-ILD) Study

  • University of Miami Hospital and Clinics, Miami
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 25 ago 2026 · NCT07486869

RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis

  • Mayo Clinic Florida, Jacksonville
ReclutandoFase 2/3
Edades de 18 a 75 · Todos los sexos · Actualizado el 17 ago 2026 · NCT06328777

An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  • USA006, Naples
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 ago 2026 · NCT07234032

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

  • University of Florida, Gainesville
  • University of South Florida, Tampa
ReclutandoEstudio observacional
Edades de 21 en adelante · Todos los sexos · Actualizado el 12 ago 2026 · NCT01915511

A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)

  • Mayo Clinic of Florida, Jacksonville
ReclutandoFase 2
Edades de 18 a 80 · Todos los sexos · Actualizado el 10 ago 2026 · NCT07175038

Abatacept for the Treatment of Common Variable Immunodeficiency With Interstitial Lung Disease

  • University of South Florida, Tampa
ReclutandoFase 2
Edades de 4 en adelante · Todos los sexos · Actualizado el 22 jul 2026 · NCT04925375

Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)

  • Ascension Medical Group St. Vincent's Lung Institute, Jacksonville
  • Mayo Clinic, Jacksonville
  • TGH/USF Center for Advanced Lung Disease and Lung Transplant, Tampa
  • y 1 más
ReclutandoFase 3
Edades de 18 en adelante · Todos los sexos · Actualizado el 13 jul 2026 · NCT05943535

An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

  • Advent Health, Orlando
  • Tampa General Hospital Center of Research Excellence, Tampa
ReclutandoEstudio observacional
Edades de 18 a 80 · Todos los sexos · Actualizado el 26 jun 2026 · NCT06129240

Home-based Pulmonary Rehabilitation and Health Coaching in Patients With Fibrotic Interstitial Lung Disease

  • Mayo Clinic in Florida, Jacksonville
Reclutando
Edades de 18 en adelante · Todos los sexos · Actualizado el 20 mar 2026 · NCT06751069

Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease

  • Maule Stem Cell Research Institute, Venice
ReclutandoFase 1
Edades de 18 en adelante · Todos los sexos · Actualizado el 29 ene 2026 · NCT07372989

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

  • Florida Lung Asthma and Sleep Specialist, Celebration
  • Central Florida Pulmonary Group, P.A. (CFPG) - Downtown Orlando, Orlando
ReclutandoFase 2
Edades de 40 en adelante · Todos los sexos · Actualizado el 12 nov 2025 · NCT05975983

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

  • aTyr Investigative Site, Miami
ReclutandoFase 2
Edades de 18 en adelante · Todos los sexos · Actualizado el 7 may 2025 · NCT05892614

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.